Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish a list of medicines deemed to be priced excessively by (a) his Department and (b) the Competition and Markets Authority.

Concerns about potential drug pricing abuses are a matter for the Competition and Markets Authority (CMA). The CMA has several ongoing investigations into excessive prices of generic medicines. Where it has concerns about the price of a generic medicine, the Department asks the CMA to investigate that price.